X4 Pharmaceuticals, Inc.【XFOR】 研究開発費の推移

機能の使い方
(単位:千ドル) 研究開発費 前年比(%)
4Q25 18,521 -14.7%
3Q25 17,337 -9.6%
2Q25 18,352 -12.3%
1Q25 18,513 -6.8%
4Q24 21,702 +42.1%
3Q24 19,173 +0.5%
2Q24 20,914 +34.1%
1Q24 19,854 -10.0%
4Q23 15,272 -19.7%
3Q23 19,081 +35.2%
3Q23 15,601 +12.9%
3Q23 22,063 +56.3%
4Q22 19,014 +56.3%
3Q22 14,110 +7.0%
2Q22 13,821 +4.8%
1Q22 14,113 +16.6%
4Q21 12,162 -1.1%
3Q21 13,188 +15.9%
2Q21 13,193 +41.2%
1Q21 12,104 +35.8%
4Q20 12,298 +74.1%
3Q20 11,381 +32.5%
2Q20 9,342 +5.5%
1Q20 8,911 +57.6%
4Q19 7,065 +62.6%
3Q19 8,589 -10.3%
2Q19 8,854 -0.9%
1Q19 5,655 -30.5%
4Q18 4,344 -
3Q18 9,572 -
2Q18 8,930 -
1Q18 8,133 -